Ozempic vs. Traditional Therapies for Type 2 Diabetes: A Systematic Review
Loading...
Authors
Rector, Zachary
Date of Issue
2024
Type
Presentation
Language
en_US
Subject Keywords
Other Titles
Abstract
Objective: To review studies conducted on the Type 2 Diabetes (T2D) treatment Ozempic in comparison to traditional treatments, with the variables measured being average HbA1c and weight loss.
Methods: Literature was gathered primarily through PubMed, with an emphasis on studies examining Ozempic in contrast to other T2D treatments. Dosage level effectiveness of Ozempic, efficacy in comparison to other treatments, and success over a given period were examined.
Results: Ozempic was more effective at reducing average HbA1C and weight of trial participants in comparison to traditional treatments, such as insulin therapy and Lixisenatide. Tirzapeptide, a T2D treatment released in 2023, was more effective than Ozempic for reducing average HbA1C and weight in T2D patients in two trials.
Conclusion: Ozempic was found to be more effective than traditional treatments for T2D in terms of HbA1C and average weight reduction. Further research should be conducted comparing the efficacy of Trizapeptide in comparison to Ozempic.